GSK plc

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1131399 London, X0

Position in LYEL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$30,343,939

-$16,215,705 QoQ

Shares Held

1,512,659

0.0% QoQ

Ownership

6.48%

of shares outstanding

% of Portfolio

5.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GSK plc holds $589,621,639 across 12 Biotechnology names. LYEL ranks #6 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	3,220,627	$153,205,226
2	WVE	Wave Life Sciences Ltd.	18,245,691	$132,281,259
3	BNTX	BioNTech SE	889,824	$79,087,557
4	VIR	Vir Biotechnology, Inc.	8,550,954	$76,616,547
5	IDYA	IDEAYA Biosciences, Inc.	1,333,333	$44,426,655
6	LYEL	Lyell Immunopharma, Inc. This page	1,512,659	$30,343,939
7	CYTK	Cytokinetics Inc	340,434	$22,438,004
8	SPRO	Spero Therapeutics, Inc.	9,190,606	$21,506,018

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,343,939	1,512,659	0.0%	Shares	Sole	2026-05-14
2025-12-31	$46,559,644	1,512,659	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.